ATNM logo

ATNM CapEx to Revenue

Current (TTM)1.66%
ATNM CapEx/Revenue (0.00% → 1.66%)
High-resolution chart · PNG

ATNM capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
115.5556%
0%
188.8889%
35.534%
11.6259%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.